Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 12, 2009
Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disorders
M W Lawless, S Norris, K J O'Byrne, et al.
Gene Expression
|
April 15, 2003
Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways
S G Gray, A H Iglesias, B T Teh, et al.
The International Journal of Developmental Biology
|
August 26, 1998
Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development
X Li, S G Gray, F Flam, et al.
British Journal of Cancer
|
September 20, 2000
Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas
S G Gray, S Kytölä, T Matsunaga, et al.
Genomics
|
October 23, 1998
Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping
R Betz, S G Gray, C Ekström, et al.
International Journal of Molecular Medicine
|
December 22, 1999
Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma
S G Gray, S Kytola, W O Lui, et al.
International Journal of Oncology
|
March 11, 2004
Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines
S G Gray, C-N Qian, K Furge, et al.
Experimental Cell Research
|
December 10, 1999
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells
S G Gray, T Yakovleva, W Hartmann, et al.
International Journal of Oncology
|
September 20, 2001
Differential expression of class I HDACs: roles of cell density and cell cycle
F Dangond, M Henriksson, G Zardo, et al.
Cytokine
|
July 6, 2000
IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a
S G Gray, I Svechnikova, W Hartmann, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Endocrine, Metabolic & Immune Disorders Drug Targets
|
March 12, 2009
Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disorders
M W Lawless, S Norris, K J O'Byrne, et al.
Gene Expression
|
April 15, 2003
Modulation of splicing events in histone deacetylase 3 by various extracellular and signal transduction pathways
S G Gray, A H Iglesias, B T Teh, et al.
The International Journal of Developmental Biology
|
August 26, 1998
Developmental-dependent DNA methylation of the IGF2 and H19 promoters is correlated to the promoter activities in human liver development
X Li, S G Gray, F Flam, et al.
British Journal of Cancer
|
September 20, 2000
Comparative genomic hybridization reveals population-based genetic alterations in hepatoblastomas
S G Gray, S Kytölä, T Matsunaga, et al.
Genomics
|
October 23, 1998
Human histone deacetylase 2, HDAC2 (Human RPD3), is localized to 6q21 by radiation hybrid mapping
R Betz, S G Gray, C Ekström, et al.
International Journal of Molecular Medicine
|
December 22, 1999
Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma
S G Gray, S Kytola, W O Lui, et al.
International Journal of Oncology
|
March 11, 2004
Microarray profiling of the effects of histone deacetylase inhibitors on gene expression in cancer cell lines
S G Gray, C-N Qian, K Furge, et al.
Experimental Cell Research
|
December 10, 1999
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells
S G Gray, T Yakovleva, W Hartmann, et al.
International Journal of Oncology
|
September 20, 2001
Differential expression of class I HDACs: roles of cell density and cell cycle
F Dangond, M Henriksson, G Zardo, et al.
Cytokine
|
July 6, 2000
IGF-II and IL-2 act synergistically to alter HDAC1 expression following treatments with trichostatin a
S G Gray, I Svechnikova, W Hartmann, et al.
Page
of 3